Estrogen formation in endometrial and cervix cancer cell lines: Involvement of aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12)

Molecular and Cellular Endocrinology

Volumn 301, Issue 1-2, 2009, Pages 142-145

  Fournier, Michelle Audrey ^a   Poirier, Donald ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

17 Hydroxysteroid dehydrogenase; Aromatase; Endometrial cancer; Enzyme; Inhibitor; Steroid sulfatase

Indexed keywords

AROMATASE; STERYL SULFATASE; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL TRANSFORMATION; ENDOMETRIUM CANCER; ENZYME ACTIVITY; HUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

17-HYDROXYSTEROID DEHYDROGENASES; AROMATASE; CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGENS; ESTRONE; FEMALE; HUMANS; ISOENZYMES; STERYL-SULFATASE; UTERINE CERVICAL NEOPLASMS;

EID: 60249090902     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.08.027     Document Type: Article

References (17)

1. Bellavance E., Luu-The V., and Poirier D. First inhibitors of the steroidogenic enzyme type 7 17β-hydroxysteroid dehydrogenase. Lett. Drug Des. Discov. 1 (2004) 194-197
2. Brueggemeier R.W., Hackett J.C., and Diaz-Cruz E.S. Aromatase inhibitors in the treatment of breast cancer. Endocr. Rev. 26 (2005) 331-345
3. Bydal, P., Luu-The, V., Poirier, P., in press. Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities. Eur. J. Med. Chem., doi:10.1016/j.ejmech.2008.03.020.
4. Cadot C., Laplante Y., Kamal F., Luu-The V., and Poirier D. C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17β-hydroxysteroid dehydrogenase: chemical synthesis and biological evaluation. Bioorg. Med. Chem. 15 (2007) 714-726
5. Ciobanu L.C., Luu-The V., Martel C., Labrie F., and Poirier D. Inhibition of estrone sulphate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase. Cancer Res. 63 (2003) 6442-6446
6. + breast cancer cell proliferation induced by estrone. Bioorg. Med. Chem. 16 (2008) 1849-1860
7. Laplante Y., Rancourt C., and Poirier D. Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors. Mol. Cell. Endocrinol. 301 (2009) 146-153
8. Luu-The V. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 76 (2001) 143-151
9. Luu-The V., Tremblay P., and Labrie F. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol. Endocrinol. 20 (2006) 437-443
10. Moeller G., and Adamski J. Multifunctionality of human 17β-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 248 (2006) 47-55
11. Penning T., Steckelbroeck S., Bauman D.R., Miller M.W., Jin Y., Peehl D.M., Fung K.M., and Lin H.K. Aldo-keto reductase (AKR) 1C3: role in prostate disease and the development of specific inhibitors. Mol. Cell. Endocrinol. 248 (2006) 182-191
12. Poirier D. Inhibitors of 17β-hydroxysteroid dehydrogenases. Curr. Med. Chem. 10 (2003) 453-477
13. Reed M.J., Purohit A., Woo L.W.L., Newman S.P., and Potter B.V.L. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr. Rev. 26 (2005) 171-202
14. Smith H.J., Nicholls P.J., Simons C., and Le Lain R. Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers. Expert Opin. Ther. Patents 11 (2001) 789-824
15. Smuc T., Rupreht R., Sinkovec J., Adamski J., and Lanisnik-Rizner T. Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer. Mol. Cell. Endocrinol. 248 (2006) 114-117
16. Smuc T., and Lanisnik-Rizner T. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer. Mol. Cell. Endocrinol. 301 (2009) 74-82
17. Tremblay M.R., Boivin R., Luu-The V., and Poirier D. Inhibitors of type 1 17β-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol. J. Enzyme Inhib. Med. Chem. 20 (2005) 153-163